Mitchell Cancer Institute (University of South Alabama) — Mobile, Alabama

Mitchell Cancer Institute (University of South Alabama) is a clinical research site located in Mobile, Alabama, United States 36604.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Mitchell Cancer Institute (University of South Alabama) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Imunon.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mitchell Cancer Institute (University of South Alabama)?

Mitchell Cancer Institute (University of South Alabama) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mitchell Cancer Institute (University of South Alabama) conducted?

Mitchell Cancer Institute (University of South Alabama) has 1 clinical trials on record, with 1 currently active. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Mitchell Cancer Institute (University of South Alabama) accredited by Crixeo Health?

Mitchell Cancer Institute (University of South Alabama) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mitchell Cancer Institute (University of South Alabama)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.